Nepafenac
ILEVRO, NEVANAC
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$105.0024
No Shortage
Tier 1: 5.8%
Nepafenac reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand ILEVRO: Generic saves up to -950% per unit
Generic Manufacturers
HARROW EYE LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.